(ATPC) Agape ATP Common Stock - Ratings and Ratios

Agape ATP Corporation is a Malaysian investment holding company that operates in the health and wellness sector, offering a range of products and services aimed at promoting a healthy lifestyle. The companys business is diversified across two main segments: skin care, health, and wellness, as well as green energy. Through its programs, such as ATP Zeta Health Program and E.A.T.S., Agape ATP provides a variety of services and products that cater to different aspects of health and wellness.

The companys product portfolio includes ionized and high bioavailability nutrients, energized mineral concentrate, soy protein isolate powder, and LIVO5, among others. These products are designed to enhance absorption at the cellular level and promote overall well-being. In addition to its health and wellness offerings, Agape ATP also provides renewable energy products, technical solutions, installations, and maintenance services, aligning with its green energy segment. The companys commitment to environmental stewardship is reflected in its efforts to promote sustainability and energy savings.

From a technical analysis perspective, the stocks current price is 2.05, sitting at the 20-day Simple Moving Average (SMA). The 50-day SMA and 200-day SMA are at 1.55 and 1.59, respectively, indicating a potential bullish trend as the short-term and long-term averages are being crossed upwards. The Average True Range (ATR) is 0.30, which translates to a volatility of 14.55%. The stock has experienced a significant range in the past 52 weeks, with a high of 6.20 and a low of 0.92.

Fundamentally, Agape ATP Corporation has a market capitalization of 75.01M USD. However, the companys financial health is a concern, as indicated by a Return on Equity (RoE) of -85.50. The absence of a Price-to-Earnings (P/E) ratio, both current and forward, further suggests that the company is not profitable at the earnings level.

Given the technical and fundamental data, a forecast for Agape ATP Corporations stock can be formulated. While the technical indicators suggest a potential for short-term bullishness due to the SMA crossovers, the high volatility (ATR of 0.30 or 14.55%) indicates a risk of significant price swings. On the fundamental side, the negative RoE and lack of P/E ratio are red flags, suggesting underlying financial challenges. Therefore, a cautious approach is warranted. A potential strategy could involve closely monitoring the stocks price action around key technical levels (SMA20, SMA50, SMA200) and waiting for a confirmation of a sustained trend before making a significant investment. Additionally, keeping an eye on future earnings announcements and any developments in the companys financial health will be crucial.